000			02301 a2200721 4500
005			20250517013323.0
264		0	_c20150601
008			201506s 0 0 eng d
022			_a1527-3350
024	7		_a10.1002/hep.27726 _2doi
040			_aNLM _beng _cNLM
100	1		_aNelson, David R
245	0	0	_aAll-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. _h[electronic resource]
260			_bHepatology (Baltimore, Md.) _cApr 2015
300			_a1127-35 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aCarbamates
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPyrrolidines
650	0	4	_aSofosbuvir
650	0	4	_aTime Factors
650	0	4	_aUridine Monophosphate _xadministration & dosage
650	0	4	_aValine _xanalogs & derivatives
650	0	4	_aYoung Adult
700	1		_aCooper, James N
700	1		_aLalezari, Jacob P
700	1		_aLawitz, Eric
700	1		_aPockros, Paul J
700	1		_aGitlin, Norman
700	1		_aFreilich, Bradley F
700	1		_aYounes, Ziad H
700	1		_aHarlan, William
700	1		_aGhalib, Reem
700	1		_aOguchi, Godson
700	1		_aThuluvath, Paul J
700	1		_aOrtiz-Lasanta, Grisell
700	1		_aRabinovitz, Mordechai
700	1		_aBernstein, David
700	1		_aBennett, Michael
700	1		_aHawkins, Trevor
700	1		_aRavendhran, Natarajan
700	1		_aSheikh, Aasim M
700	1		_aVarunok, Peter
700	1		_aKowdley, Kris V
700	1		_aHennicken, Delphine
700	1		_aMcPhee, Fiona
700	1		_aRana, Khurram
700	1		_aHughes, Eric A
773	0		_tHepatology (Baltimore, Md.) _gvol. 61 _gno. 4 _gp. 1127-35
856	4	0	_uhttps://doi.org/10.1002/hep.27726 _zAvailable from publisher's website
999			_c24559177 _d24559177